Alcohol and Breast Cancer Risk
Drinking as little as half a glass of wine a day may raise a woman's risk of developing breast cancer, a new study shows.
May 16, 2005 (Orlando, Fla.) -- Alcohol may be good for your heart in moderation, but drinking as little as half a glass of a new study shows.
And don't think that switching to beer or spirits is the answer: The more alcohol consumed on a regular basis, the greater the risk, says Wendy Y. Chen, MD, PhD, a cancer specialist at the Dana-Farber Cancer Institute in Boston.
The study was presented at the annual meeting of the American Society of Clinical Oncology.
Chen notes that women thinking about having a few glasses of wine a day for their heart-healthy effects need to figure in the new findings when weighing the risks and benefits. She stresses that "its only regular, repeated use that increases the chance of breast cancer. For most women, having a glass of wine or beer on occasion is not a problem."
Postmenopausal Women at Greatest Risk
Previous estrogen. Many breast cancers are fueled by the hormone estrogen. Therefore, regular use of alcohol is thought to increase the risk of breast cancer by increasing bloodestrogen levels.
Alcohol may change the way the body metabolizes
The new study tracked the health of 122,000 women since 1976. They were free of cancer at the start of the study. Every four years, the women were asked how much alcohol they had used during an average month in the past year.
By 2002, nearly 6,000 of the women developed breast cancer.
When compared with teetotalers:
- Women who drank the equivalent of a half glass of wine a day were 6% more likely to develop breast cancer.
- Women who drank a glass or two a day faced a 21% increased risk of breast cancer.
- Those who drank more than two drinks a day were 37% more likely to develop breast cancer.
However, the risk was much greater in menopausal women:
- Menopausal women who drank a half glass of wine daily increased their chance of breast cancer by 18%.
The elevated risk was also more pronounced for women whose tumor growth was fueled by the hormones estrogen or progesterone -- a group that accounts for about 70% of women with breast cancer.